Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK

INTRODUCTION: This analysis was conducted to assess the incidence of adverse clinical outcomes, healthcare resource use (HCRU), and the costs associated with systemic corticosteroid (SCS) use in adults with systemic lupus erythematosus (SLE) in the UK. METHODS: We identified incident SLE cases using...

Descripción completa

Detalles Bibliográficos
Autores principales: Stirnadel-Farrant, Heide A., Golam, Sarowar M., Naisbett-Groet, Barbara, Gibson, Danny, Langham, Julia, Langham, Sue, Samnaliev, Mihail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469132/
https://www.ncbi.nlm.nih.gov/pubmed/37400682
http://dx.doi.org/10.1007/s40744-023-00566-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469132/
https://www.ncbi.nlm.nih.gov/pubmed/37400682
http://dx.doi.org/10.1007/s40744-023-00566-w

Ejemplares similares